Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stuttgart - Delayed Quote EUR

Cencora, Inc. (ABG.SG)

Compare
253.80
-9.90
(-3.75%)
At close: April 4 at 9:57:19 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Steven H. Collis Executive Chairman 5.41M 19.29M 1961
Dr. Robert P. Mauch Ph.D., PharmD President, CEO & Director 2.95M 4.46M 1967
Mr. James F. Cleary Jr. Executive VP & CFO 2.18M 4.13M 1963
Ms. Elizabeth S. Campbell J.D. Executive VP & Chief Legal Officer 1.78M 530.8k 1975
Ms. Silvana Battaglia Executive VP & Chief Human Resources Officer 1.56M 449.47k 1968
Mr. Lazarus Krikorian Senior VP, Chief Accounting Officer & Corporate Controller -- -- 1965
Mr. Pawan Singh Verma Executive VP and Chief Data & Information Officer -- -- 1977
Mr. Bennett S. Murphy Senior VP, Head of Investor Relations & Treasury -- -- --
Ms. Jennifer E. Dubas Senior VP & Chief Compliance Officer -- -- --
Mr. Richard Tremonte EVP and President of U.S. Pharmaceuticals & Animal Health -- -- --

Cencora, Inc.

1 West First Avenue
Conshohocken, PA 19428-1800
United States
(610) 727-7000 https://www.cencora.com
Sector: 
Healthcare
Full Time Employees: 
46,000

Description

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Corporate Governance

Cencora, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 6. The pillar scores are Audit: 6; Board: 8; Shareholder Rights: 7; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 7, 2025 at 12:30 PM UTC

Cencora, Inc. Earnings Date

Recent Events

February 14, 2025 at 12:00 AM UTC

Ex-Dividend Date